Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Legionnaires’ Disease Provides New Insights on Bacterial Systems
Disease Discoveries

Legionnaires’ Disease Provides New Insights on Bacterial Systems

By Sarah PlumridgeJan 29, 2015
Share
Facebook Twitter Email
Legionella pneumophila, the bacteria associated with Legionnaire’s disease, a severe form of pneumonia spread by inhalation of water contaminated with the bacteria. Photo Credit: CDC

Northwestern Medicine scientists have revealed a new role for a protein in Legionella pneumophila, a bacteria that replicates in amoebae in natural and manmade water systems, causing Legionnaires’ disease.

In a paper published in Infection and Immunity, they demonstrated that this protein, Cas2, has nucleus activity, or the ability to cleave the bonds between nucleic acids including RNA and DNA.

“We think this protein is modifying bacterial RNA expression so that L. pneumophila virulence toward amoebae is expressed more effectively,” said Nicholas Cianciotto, PhD, professor in Microbiology-Immunology.

Previously, Cianciotto and his co-authors had showed in a paper published in mBio that the Cas2 protein promotes Legionella infection of different species of amoebae. In addition to providing a place to grow and replicate, the amoebae host can protect the bacteria from biocides that would normally kill the organism.

“The bacteria become amplified by growing in the amoebae and as a result, are more likely to be aerosolized and inhaled by us,” Cianciotto said. “Amoebae are important in the transmission of the disease-causing bacteria from the environment to the human host, so the fact that this protein promotes infection of amoebae by L. pneumophila is quite significant in terms of understanding the genesis of disease.”

In this study, the Cianciotto lab created different forms of Cas2 and compared them to identify the active part of the protein. They then mutated Cas2 in the Legionella bacteria and found the mutant bacteria had a diminished ability to infect the amoebae.

Taking this research one step further, Cianciotto and his co-authors inserted the gene that codes for Cas2 into a strain of L. pneumophila that naturally lacks the gene and discovered that it caused the strain to become more infectious for amoebae.

Nicholas Cianciotto, PhD, professor in Microbiology-Immunology, whose lab revealed a new role for a protein involved in the replication of the bacteria that causes Legionnaires’ disease. 

 

“This suggests that in the natural environment, there is a selective advantage for strains to acquire this gene and to retain it,” he said.

Cianciotto said the paper not only defines a new virulence component of the Legionella bacterium but also provides insight into how the Cas family of proteins function and work in a larger system, called CRISPR-Cas. This system has previously been described as providing bacteria with immunity against phages – viruses that infect bacteria – but the study shows that proteins in the CRISPR-Cas system have other responsibilities, as well.

“We have this idea that bacteria evolved the CRISPR-Cas system for phage immunity, but parts of this system can do other things. It is a real documentation of the way bacteria are very effective at using their small genomes to do many different things,” he said.

Cianciotto thinks these studies will prompt similar studies with other bacterial species and that further research on the enzymology of Cas2 proteins is needed.

In ongoing research, Cianciotto is collaborating with Wayne F. Anderson, PhD, professor in Biochemistry and Molecular Genetics, to determine the structure of L. pneumophila Cas2 and compare it to other proteins to discover any unique structural attributes.

Other futures studies will include finding the target(s) for the Cas2 activity in L. pneumophila and learning why the Cas2 mutant doesn’t grow well in the amoebae.

Finally, Cianciotto noted that this area of research serves as a reminder of how systems in primitive bacteria can have wider implications and applications.  Indeed, another nuclease component of the CRISPR-Cas systems, Cas9, is being widely utilized in a new form of genomic engineering.

In addition to Cianciotto, this study was performed by post-doctoral fellow Felizza Gunderson and Driskill Graduate Program in Life Sciences students Celeste Mallama and Stephanie Fairbairn.

This research was funded by the National Institutes of Health grant R21AI103451.

Biochemistry Microbiology Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
pride7
pride6
pride5
pride4
pride3
pride2
pride1
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.